Efficacy and toxicities of gemcitabine and cisplatin combined with endostar in advanced thymoma and thymic carcinoma

Efficacy and toxicities of gemcitabine and cisplatin combined with endostar in advanced thymoma and thymic carcinoma

Background Thymoma and thymic carcinoma are rare thymic epithelial tumors. We investigated the efficacy of first‐line gemcitabine and cisplatin (GP) chemotherapy versus gemcitabine and cisplatin chemotherapy combined with the anti‐angiogenic drug endostar (GP + E) in advanced thymoma and thymic carc...

Full description

Bibliographic Details
Main Authors: Yang Wang, Jun Nie, Ling Dai, Weiheng Hu, Xiaoling Chen, Jindi Han, Xiangjuan Ma, Guangming Tian, Sen Han, Jieran Long, Ziran Zhang, Jian Fang
Format: Article
Language:English
Published: Wiley 2019-01-01
Series:Thoracic Cancer
Subjects:
Chemotherapy
thymic carcinoma
thymoma
targeted therapy
Online Access:https://doi.org/10.1111/1759-7714.12891

Internet

https://doi.org/10.1111/1759-7714.12891

Similar Items